Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly's Ramucirumab for lung cancer meets Phase III survival endpoint
Eli Lilly's Ramucirumab for lung cancer meets Phase III survival endpoint
Eli Lilly's Ramucirumab for lung cancer meets Phase III survival endpoint
Submitted by
admin
on February 19, 2014 - 8:41am
Source:
Yahoo/Fly on the Wall
News Tags:
Eli Lilly
ramucirumab
non-small cell lung cancer
Headline:
Eli Lilly's Ramucirumab for lung cancer meets Phase III survival endpoint
Do Not Allow Advertisers to Use My Personal information
